APA

Bláha V., Bláha M., Lánská M., Havel E., Vyroubal P., Zadák Z. & Žák P. (20190510). [The role of PCSK9-inhibitors and of lipoprotein apheresis in the treatment of homozygous and severe heterozygous familial hypercholesterolemia: A rivalry, or are things quite different?]. : Vnitrni lekarstvi.

Chicago

Bláha Vladimír, Bláha Milan, Lánská Miriam, Havel Eduard, Vyroubal Pavel, Zadák Zdeněk and Žák Pavel. 20190510. [The role of PCSK9-inhibitors and of lipoprotein apheresis in the treatment of homozygous and severe heterozygous familial hypercholesterolemia: A rivalry, or are things quite different?]. : Vnitrni lekarstvi.

Harvard

Bláha V., Bláha M., Lánská M., Havel E., Vyroubal P., Zadák Z. and Žák P. (20190510). [The role of PCSK9-inhibitors and of lipoprotein apheresis in the treatment of homozygous and severe heterozygous familial hypercholesterolemia: A rivalry, or are things quite different?]. : Vnitrni lekarstvi.

MLA

Bláha Vladimír, Bláha Milan, Lánská Miriam, Havel Eduard, Vyroubal Pavel, Zadák Zdeněk and Žák Pavel. [The role of PCSK9-inhibitors and of lipoprotein apheresis in the treatment of homozygous and severe heterozygous familial hypercholesterolemia: A rivalry, or are things quite different?]. : Vnitrni lekarstvi. 20190510.